Fig. 2
From: The “Great Debate” at Immunotherapy Bridge 2020, December 3rd, 2020
Is anti-PD-1/PD-L1 a backbone for immunotherapy combination: yes or no? Audience response before and after debate
Fig. 2 | Journal of Translational Medicine